Real-time US stock market breadth indicators and technical analysis to gauge overall market health and direction. We provide comprehensive market timing tools that help you make better decisions about when to be aggressive or defensive.
Becton Dickinson and Company (BDX), a global medical technology provider focused on diagnostic tools, medication delivery systems, and laboratory equipment, is trading at $155.23 as of 2026-04-06, marking a 0.47% gain in the most recent trading session. This analysis outlines key technical levels, broader market context, and potential near-term scenarios for the stock, with no recent earnings data available to inform fundamental performance assessments at this time. Key takeaways include a neutr
Is BD (BDX) Stock Near Support | Price at $155.23, Up 0.47% - Crowd Consensus Signals
BDX - Stock Analysis
3,007 Comments
1,649 Likes
1
Krystalrose
Engaged Reader
2 hours ago
I should’ve waited a bit longer before deciding.
👍 82
Reply
2
Jannice
Regular Reader
5 hours ago
This confirms I acted too quickly.
👍 197
Reply
3
Stevanna
Consistent User
1 day ago
As a beginner, I didn’t even know to look for this.
👍 244
Reply
4
Carolos
Daily Reader
1 day ago
I can’t help but think “what if”.
👍 45
Reply
5
Jenali
Community Member
2 days ago
This would’ve given me more confidence earlier.
👍 125
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.